Hui Liu

机构：Memorial Sloan Kettering Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Beijing Hospital, Peking University People's Hospital · ORCID：0000-0002-8166-0216

发表论文 314 篇 · 总被引 3094 次 · h-index 27

代表论文

• Longitudinal ultra-sensitive mutation burden sequencing for precise minimal residual disease assessment in AML (2024 · Nature Communications · 被引 10)
• Efficacy and safety of venetoclax and azacitidine for acute myeloid leukemia in China: a real-world single-center study (2025 · BMC Cancer · 被引 7)
• Peptide-based hydrogel co-assembled with antibody-drug for enhanced retinal cell uptake and attenuated experimental autoimmune uveitis (2025 · European Journal of Pharmaceutics and Biopharmaceutics · 被引 6)
• Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myeloma (2025 · BMC Cancer · 被引 5)
• A mouse coccygeal intervertebral disc degeneration model with tail‐looping constructed using a suturing method (2025 · Animal Models and Experimental Medicine · 被引 4)
• Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China (2025 · Cancer Medicine · 被引 4)